AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Emera Incorporated

$49.01 -$0.22 (-0.45%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$49.19
Day Range
$48.74$49.44
Year Range
$45.77$55.49
Market Cap
14.99B
AVG Volume
447.17K
Trailing/Forward PE
21.5/18.73
PEG ratio
-7.31
Dividend Yield
4.30%
Next Earnings Date
2026-11-06
Primary Exchange
New York Stock ExchangeUS
Revenue (CAD) · TTM
02.5B5B7.5B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q28.58B
26 Q18.59B
25 Q48.79B
25 Q38.53B
25 Q28.23B
25 Q17.86B
24 Q47.2B
24 Q37.41B
24 Q27.35B
24 Q17.15B
Net Income (CAD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q21.04B
26 Q11.07B
25 Q41.09B
25 Q31.18B
25 Q2950M
25 Q1943M
24 Q4567M
24 Q3701M
24 Q2796M
24 Q1693M
Operating Income (CAD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q21.65B
26 Q11.61B
25 Q41.91B
25 Q31.94B
25 Q21.68B
25 Q11.57B
24 Q41.08B
24 Q31.35B
24 Q21.4B
24 Q11.34B
EBITDA (CAD) · TTM
01B2B3B4B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q23.13B
26 Q13.16B
25 Q43.22B
25 Q33.16B
25 Q23.31B
25 Q13.1B
24 Q42.6B
24 Q32.84B
24 Q22.64B
24 Q12.55B
Cash Flows (CAD) · TTM
-2B-1.5B-1B-500M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q2-1.12B
26 Q1-1.81B
25 Q4-1.73B
25 Q3-1.21B
25 Q2-1.27B
25 Q1-498M
24 Q4-505M
24 Q3-722M
24 Q2-450M
24 Q1-544M
EPS (CAD) · TTM
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q23.17
26 Q13.28
25 Q43.39
25 Q33.69
25 Q22.94
25 Q12.94
24 Q41.71
24 Q32.23
24 Q22.59
24 Q12.3
Expenses (CAD) · TTM
01B2B3B4BSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q23.33B
26 Q13.45B
25 Q43.55B
25 Q33.56B
25 Q23.59B
25 Q13.34B
24 Q43.22B
24 Q33.17B
24 Q23B
24 Q12.97B
Shares Outstanding · TTM
-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EMA Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q3-28M
24 Q2-28M
24 Q1-28M
Dividends (CAD)
00.20.40.6Aug 24Oct 24Nov 24Jan 25May 25Aug 25Oct 25Jan 26May 26Jul 26
EMA Dividends (CAD) by quarter
PeriodDividends (CAD)
Jul 260.52
May 260.54
Jan 260.54
Oct 250.52
Aug 250.53
May 250.53
Jan 250.5
Nov 240.52
Oct 240.54
Aug 240.52
PE Ratio
1520253035med 20.41Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA PE Ratio by quarter
PeriodPE Ratio
Sep 2620
Sep 2620.07
Sep 2620.49
Aug 2620.41
Aug 2620.28
Aug 2621.02
Aug 2620.05
Jul 2621.38
Jul 2621.92
Jul 2621.87
Jul 2621.37
Jul 2621.46
Jun 2621.61
Jun 2620.73
Jun 2620.81
Jun 2620.42
May 2620.36
May 2620.77
May 2620.08
May 2620.36
May 2619.95
Apr 2619.91
Apr 2619.91
Apr 2620.48
Apr 2620.33
Mar 2619.78
Mar 2619.49
Mar 2620.34
Mar 2619.66
Feb 2619.67
Feb 2617.95
Feb 2617.93
Feb 2617.27
Jan 2617.26
Jan 2617.46
Jan 2617.52
Jan 2617.4
Jan 2617.29
Dec 2517.19
Dec 2517.04
Dec 2516.88
Dec 2516.78
Nov 2517.47
Nov 2517.1
Nov 2517.18
Nov 2521.16
Oct 2520.95
Oct 2521.75
Oct 2521.74
Oct 2521.55
Oct 2520.97
Sep 2520.66
Sep 2520.02
Sep 2520.35
Sep 2520.33
Aug 2520.61
Aug 2520.85
Aug 2520.78
Aug 2521.06
Aug 2520.31
Jul 2520.15
Jul 2519.73
Jul 2519.86
Jul 2519.46
Jun 2519.37
Jun 2519.1
Jun 2519.3
Jun 2518.99
May 2519.84
May 2532.2
May 2531.33
May 2532.15
May 2531.65
Apr 2532.03
Apr 2531.85
Apr 2530.95
Apr 2531.73
Mar 2531.32
Mar 2530.76
Mar 2530.86
Mar 2530.77
Feb 2523.91
Feb 2523.63
Feb 2523.39
Feb 2522.96
Jan 2522.88
Jan 2522.58
Jan 2522.54
Jan 2521.65
Jan 2522.28
Dec 2422.31
Dec 2422.17
Dec 2422.61
Dec 2423.06
Nov 2422.08
Nov 2418.59
Nov 2418.28
Nov 2418.15
Nov 2418.34
Oct 2419.17
Free Cash Flow Yield
-10%-8%-6%-4%-2%med -5.89%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-5.39%
Sep 26-5.37%
Sep 26-5.26%
Aug 26-5.28%
Aug 26-5.31%
Aug 26-5.12%
Aug 26-8.42%
Jul 26-7.89%
Jul 26-7.7%
Jul 26-7.72%
Jul 26-7.9%
Jul 26-7.86%
Jun 26-7.81%
Jun 26-8.14%
Jun 26-8.11%
Jun 26-8.26%
May 26-8.29%
May 26-8.12%
May 26-8.4%
May 26-8.29%
May 26-7.96%
Apr 26-7.98%
Apr 26-7.98%
Apr 26-7.75%
Apr 26-7.81%
Mar 26-8.03%
Mar 26-8.15%
Mar 26-7.81%
Mar 26-8.08%
Feb 26-8.08%
Feb 26-5.74%
Feb 26-5.74%
Feb 26-5.96%
Jan 26-5.97%
Jan 26-5.9%
Jan 26-5.88%
Jan 26-5.92%
Jan 26-5.96%
Dec 25-5.99%
Dec 25-6.04%
Dec 25-6.1%
Dec 25-6.14%
Nov 25-5.9%
Nov 25-6.02%
Nov 25-5.99%
Nov 25-6.33%
Oct 25-6.39%
Oct 25-6.16%
Oct 25-6.16%
Oct 25-6.21%
Oct 25-6.39%
Sep 25-6.48%
Sep 25-6.69%
Sep 25-6.58%
Sep 25-6.58%
Aug 25-6.5%
Aug 25-6.42%
Aug 25-6.44%
Aug 25-6.36%
Aug 25-2.6%
Jul 25-2.62%
Jul 25-2.68%
Jul 25-2.66%
Jul 25-2.71%
Jun 25-2.73%
Jun 25-2.77%
Jun 25-2.74%
Jun 25-2.78%
May 25-2.66%
May 25-2.77%
May 25-2.84%
May 25-2.77%
May 25-2.81%
Apr 25-2.78%
Apr 25-2.8%
Apr 25-2.88%
Apr 25-2.81%
Mar 25-2.84%
Mar 25-2.9%
Mar 25-2.89%
Mar 25-2.89%
Feb 25-4.31%
Feb 25-4.36%
Feb 25-4.4%
Feb 25-4.49%
Jan 25-4.5%
Jan 25-4.56%
Jan 25-4.57%
Jan 25-4.76%
Jan 25-4.62%
Dec 24-4.62%
Dec 24-4.65%
Dec 24-4.56%
Dec 24-4.47%
Nov 24-4.67%
Nov 24-3.04%
Nov 24-3.09%
Nov 24-3.11%
Nov 24-3.08%
Oct 24-2.95%
Price to Sales
1.822.22.42.62.8med 2.42Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA Price to Sales by quarter
PeriodPrice to Sales
Sep 262.43
Sep 262.44
Sep 262.49
Aug 262.48
Aug 262.46
Aug 262.55
Aug 262.5
Jul 262.67
Jul 262.73
Jul 262.73
Jul 262.67
Jul 262.68
Jun 262.7
Jun 262.59
Jun 262.6
Jun 262.55
May 262.54
May 262.59
May 262.51
May 262.54
May 262.47
Apr 262.47
Apr 262.47
Apr 262.54
Apr 262.52
Mar 262.45
Mar 262.42
Mar 262.52
Mar 262.44
Feb 262.44
Feb 262.47
Feb 262.47
Feb 262.38
Jan 262.38
Jan 262.4
Jan 262.41
Jan 262.4
Jan 262.38
Dec 252.37
Dec 252.35
Dec 252.32
Dec 252.31
Nov 252.41
Nov 252.35
Nov 252.37
Nov 252.44
Oct 252.42
Oct 252.51
Oct 252.51
Oct 252.49
Oct 252.42
Sep 252.39
Sep 252.31
Sep 252.35
Sep 252.35
Aug 252.38
Aug 252.41
Aug 252.4
Aug 252.43
Aug 252.44
Jul 252.42
Jul 252.37
Jul 252.38
Jul 252.34
Jun 252.32
Jun 252.29
Jun 252.32
Jun 252.28
May 252.38
May 252.54
May 252.47
May 252.53
May 252.49
Apr 252.52
Apr 252.51
Apr 252.44
Apr 252.5
Mar 252.47
Mar 252.42
Mar 252.43
Mar 252.42
Feb 252.26
Feb 252.24
Feb 252.21
Feb 252.17
Jan 252.17
Jan 252.14
Jan 252.13
Jan 252.05
Jan 252.11
Dec 242.11
Dec 242.1
Dec 242.14
Dec 242.18
Nov 242.09
Nov 242.01
Nov 241.98
Nov 241.97
Nov 241.99
Oct 242.08
EV/EBITDA
1112131415med 12.45Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2613.6
Sep 2613.63
Sep 2613.77
Aug 2613.74
Aug 2613.7
Aug 2613.94
Aug 2611.7
Jul 2612.15
Jul 2612.33
Jul 2612.32
Jul 2612.15
Jul 2612.18
Jun 2612.23
Jun 2611.93
Jun 2611.96
Jun 2611.82
May 2611.8
May 2611.94
May 2611.71
May 2611.8
May 2613.33
Apr 2613.32
Apr 2613.31
Apr 2613.51
Apr 2613.46
Mar 2613.27
Mar 2613.17
Mar 2613.46
Mar 2613.23
Feb 2613.23
Feb 2613.14
Feb 2613.13
Feb 2612.88
Jan 2612.88
Jan 2612.96
Jan 2612.97
Jan 2612.93
Jan 2612.89
Dec 2512.85
Dec 2512.8
Dec 2512.74
Dec 2512.7
Nov 2512.96
Nov 2512.82
Nov 2512.85
Nov 2512.1
Oct 2512.04
Oct 2512.27
Oct 2512.26
Oct 2512.21
Oct 2512.04
Sep 2511.96
Sep 2511.77
Sep 2511.87
Sep 2511.86
Aug 2511.94
Aug 2512.01
Aug 2511.99
Aug 2512.07
Aug 2512.54
Jul 2512.49
Jul 2512.36
Jul 2512.4
Jul 2512.28
Jun 2512.25
Jun 2512.17
Jun 2512.23
Jun 2512.13
May 2512.39
May 2514.58
May 2514.39
May 2514.57
May 2514.46
Apr 2514.54
Apr 2514.5
Apr 2514.31
Apr 2514.48
Mar 2514.39
Mar 2514.27
Mar 2514.29
Mar 2514.27
Feb 2512.4
Feb 2512.33
Feb 2512.28
Feb 2512.17
Jan 2512.15
Jan 2512.08
Jan 2512.07
Jan 2511.85
Jan 2512
Dec 2412.01
Dec 2411.98
Dec 2412.08
Dec 2412.2
Nov 2411.95
Nov 2412.86
Nov 2412.76
Nov 2412.73
Nov 2412.78
Oct 2413.03
Price/Operating Cashflow
57.51012.515med 8.78Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 269.47
Sep 269.51
Sep 269.71
Aug 269.67
Aug 269.61
Aug 269.96
Aug 2613.17
Jul 2614.04
Jul 2614.4
Jul 2614.37
Jul 2614.04
Jul 2614.1
Jun 2614.19
Jun 2613.61
Jun 2613.67
Jun 2613.41
May 2613.37
May 2613.64
May 2613.19
May 2613.37
May 2612.06
Apr 2612.03
Apr 2612.03
Apr 2612.38
Apr 2612.29
Mar 2611.95
Mar 2611.78
Mar 2612.29
Mar 2611.88
Feb 2611.89
Feb 269.23
Feb 269.22
Feb 268.88
Jan 268.88
Jan 268.98
Jan 269.01
Jan 268.95
Jan 268.89
Dec 258.84
Dec 258.77
Dec 258.68
Dec 258.63
Nov 258.99
Nov 258.8
Nov 258.84
Nov 258.93
Oct 258.84
Oct 259.18
Oct 259.17
Oct 259.09
Oct 258.85
Sep 258.72
Sep 258.44
Sep 258.58
Sep 258.58
Aug 258.69
Aug 258.8
Aug 258.77
Aug 258.88
Aug 256.9
Jul 256.85
Jul 256.7
Jul 256.74
Jul 256.61
Jun 256.58
Jun 256.49
Jun 256.56
Jun 256.45
May 256.74
May 256.9
May 256.71
May 256.89
May 256.78
Apr 256.86
Apr 256.82
Apr 256.63
Apr 256.8
Mar 256.71
Mar 256.59
Mar 256.61
Mar 256.59
Feb 257.06
Feb 256.97
Feb 256.9
Feb 256.78
Jan 256.75
Jan 256.66
Jan 256.65
Jan 256.39
Jan 256.58
Dec 246.59
Dec 246.54
Dec 246.67
Dec 246.81
Nov 246.52
Nov 245.96
Nov 245.86
Nov 245.82
Nov 245.88
Oct 246.14
Price to Book
11.522.5med 1.48Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMA Price to Book by quarter
PeriodPrice to Book
Sep 261.45
Sep 261.45
Sep 261.48
Aug 261.48
Aug 261.47
Aug 261.52
Aug 262.1
Jul 262.24
Jul 262.3
Jul 262.29
Jul 262.24
Jul 262.25
Jun 262.27
Jun 262.17
Jun 262.18
Jun 262.14
May 262.14
May 262.18
May 262.11
May 262.14
May 261.62
Apr 261.62
Apr 261.62
Apr 261.67
Apr 261.65
Mar 261.61
Mar 261.59
Mar 261.65
Mar 261.6
Feb 261.6
Feb 261.56
Feb 261.56
Feb 261.5
Jan 261.5
Jan 261.52
Jan 261.53
Jan 261.52
Jan 261.51
Dec 251.5
Dec 251.48
Dec 251.47
Dec 251.46
Nov 251.52
Nov 251.49
Nov 251.5
Nov 251.53
Oct 251.51
Oct 251.57
Oct 251.57
Oct 251.56
Oct 251.51
Sep 251.49
Sep 251.44
Sep 251.47
Sep 251.47
Aug 251.49
Aug 251.51
Aug 251.5
Aug 251.52
Aug 251.39
Jul 251.38
Jul 251.35
Jul 251.36
Jul 251.34
Jun 251.33
Jun 251.31
Jun 251.32
Jun 251.3
May 251.36
May 251.37
May 251.34
May 251.37
May 251.35
Apr 251.37
Apr 251.36
Apr 251.32
Apr 251.35
Mar 251.34
Mar 251.31
Mar 251.32
Mar 251.31
Feb 251.35
Feb 251.33
Feb 251.32
Feb 251.29
Jan 251.29
Jan 251.27
Jan 251.27
Jan 251.22
Jan 251.26
Dec 241.26
Dec 241.25
Dec 241.27
Dec 241.3
Nov 241.24
Nov 241.18
Nov 241.16
Nov 241.15
Nov 241.16
Oct 241.21
Emera Incorporated
EMA
Stockpicker

Video analysis: EMA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EMA

Extreme Delivers Industry's First Proactive, Context-Aware AI Agent for Networking

gurufocus.com · 9 Sep 2026

Extreme Delivers Industry's First Proactive, Context-Aware AI Agent for Networking

[url="]Extreme Networks[/url], Inc. (NASDAQ: EXTR) today announced the general availability of [url="]Extreme Agent ONE™ Coworker[/url], the next generation o

Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

gurufocus.com · 18 Aug 2026

Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia PR Newswire

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

gurufocus.com · 14 Aug 2026

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing

Bernhard Capital Partners Completes Acquisition of New Mexico Gas Company

prnewswire.com · 12 Aug 2026

Bernhard Capital Partners Completes Acquisition of New Mexico Gas Company

BATON ROUGE, La., Aug. 12, 2026 /PRNewswire/ -- Bernhard Capital Partners ("Bernhard"), an infrastructure and services-focused private markets investment firm, announced today that it has closed on its previously announced acquisition of New Mexico Gas Company ("NMGC") from Emera Inc. ("Emera") (TSX/NYSE: EMA).

Emera Completes Sale of New Mexico Gas Company

businesswire.com · 12 Aug 2026

Emera Completes Sale of New Mexico Gas Company

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announced the transaction to sell New Mexico Gas Company (NMGC), a regulated natural gas utility headquartered in Albuquerque, New Mexico, to Bernhard Capital Partners has closed. The sale of NMGC was originally announced on August 5, 2024. About Emera Inc. Emera (TSX/NYSE: EMA) is a leading North American provider of energy services headquartered in Halifax, Nova Scotia, with investments in regulated electric and natural g.

Emera Q2 Earnings Call Highlights

marketbeat.com · 9 Aug 2026

Emera Q2 Earnings Call Highlights

Emera TSE: EMA reported second-quarter adjusted earnings of C$212 million, or C$0.69 per share, as the utility advanced asset sales designed to strengthen its balance sheet and concentrate investment on its regulated businesses.

Emera Reports 2026 Second Quarter Financial Results

businesswire.com · 7 Aug 2026

Emera Reports 2026 Second Quarter Financial Results

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (“Emera”) (TSX/NYSE: EMA) reported 2026 second quarter financial results1. Highlights Delivered Q2 2026 adjusted EPS2 of $0.69 and reported EPS of $0.34. Positioned to achieve 2026 adjusted EPS2 growth above the annual target range of 5-7%3 and remain committed to 5-7% adjusted EPS2 growth through 20303. Strengthened year-to-date operating cash flow4 by 8% versus the first six months of 2025. Safely advanced more than $1.7B of customer-focused i.

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

gurufocus.com · 6 Aug 2026

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

[url="]PepGen Inc.[/url] (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of tran

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.